Portfolio von SECTORAL ASSET MANAGEMENT INC
71 gemeldete Positionen · zum 31.03.2026
Originalmeldung · Zehn größte Positionen: 49.8 % des Aktienteils
Aufteilung nach Branche
- Gesundheit 52,4 %
- Industrie 0,5 %
- Rohstoffe 0,2 %
- Nicht zugeordnet 46,8 %
Einstufung von Titelia, Gesellschaft für Gesellschaft. Der nicht zugeordnete Anteil bleibt sichtbar.
Aufteilung nach Währung
Die gemeldete Notierungswährung jeder Position.
Länderaufteilung
- US 94,6 %
- NL 2,3 %
- DE 1,8 %
- DK 0,6 %
- BE 0,4 %
- FR 0,3 %
Anteile berechnet auf den Aktienteil.
| Rang | Land | Positionen | Wert | Anteil |
|---|
| 1 | US | 66 | 110,5 Mio. $ | 94,62 % |
| 2 | NL | 1 | 2,7 Mio. $ | 2,34 % |
| 3 | DE | 1 | 2 Mio. $ | 1,75 % |
| 4 | DK | 1 | 728.276 $ | 0,62 % |
| 5 | BE | 1 | 477.295 $ | 0,41 % |
| 6 | FR | 1 | 297.861 $ | 0,26 % |
Positionen
| Rang | Gesellschaft | Stücke | Wert | Gewicht |
|---|
| 1 | Evommune Inc | 589.005 | 13,5 Mio. $ | |
| 2 | Contineum Therapeutics Inc | 727.587 | 9,5 Mio. $ | |
| 3 | Shoulder Innovations Inc | 430.407 | 6,3 Mio. $ | |
| 4 | Eli Lilly & Co | 6.354 | 5,8 Mio. $ | |
| 5 | Johnson & Johnson | 18.218 | 4,5 Mio. $ | |
| 6 | Gilead Sciences Inc | 27.490 | 4,1 Mio. $ | |
| 7 | UnitedHealth Group Inc | 14.957 | 4 Mio. $ | |
| 8 | Amgen Inc | 9.210 | 3,5 Mio. $ | |
| 9 | Vertex Pharmaceuticals Inc | 7.007 | 3,5 Mio. $ | |
| 10 | Insmed Inc | 19.668 | 3,4 Mio. $ | |
| 11 | Argenx SE | 3.564 | 2,7 Mio. $ | |
| 12 | AbbVie Inc | 12.200 | 2,7 Mio. $ | |
| 13 | Abbott Laboratories | 25.578 | 2,6 Mio. $ | |
| 14 | Merck & Co Inc | 21.480 | 2,6 Mio. $ | |
| 15 | Regeneron Pharmaceuticals, Inc. | 2.919 | 2,5 Mio. $ | |
| 16 | Intuitive Surgical Inc | 5.250 | 2,4 Mio. $ | |
| 17 | Boston Scientific Corp | 34.780 | 2,2 Mio. $ | |
| 18 | BioNTech SE | 22.164 | 2 Mio. $ | |
| 19 | Stryker Corp | 5.874 | 1,9 Mio. $ | |
| 20 | Danaher Corp | 9.597 | 1,8 Mio. $ | |
| 21 | Thermo Fisher Scientific Inc | 3.508 | 1,7 Mio. $ | |
| 22 | Dexcom Inc | 23.231 | 1,5 Mio. $ | |
| 23 | IQVIA Holdings Inc | 8.307 | 1,4 Mio. $ | |
| 24 | Summit Therapeutics Inc | 69.615 | 1,4 Mio. $ | |
| 25 | Edwards Lifesciences Corp | 17.338 | 1,4 Mio. $ | |
| 26 | Bristol-Myers Squibb Co | 21.150 | 1,3 Mio. $ | |
| 27 | United Therapeutics Corp | 1.710 | 1,1 Mio. $ | |
| 28 | Vera Therapeutics Inc | 25.573 | 1,1 Mio. $ | |
| 29 | Arcus Biosciences Inc | 45.070 | 1 Mio. $ | |
| 30 | Trevi Therapeutics Inc | 74.446 | 939.499 $ | |
| 31 | Cogent Biosciences Inc | 22.140 | 902.398 $ | |
| 32 | Mineralys Therapeutics Inc | 31.618 | 895.135 $ | |
| 33 | Alnylam Pharmaceuticals Inc | 2.310 | 864.232 $ | |
| 34 | Tarsus Pharmaceuticals Inc | 11.272 | 852.463 $ | |
| 35 | Rapport Therapeutics Inc | 25.421 | 835.005 $ | |
| 36 | Nektar Therapeutics | 10.851 | 820.662 $ | |
| 37 | Syndax Pharmaceuticals Inc | 31.680 | 787.466 $ | |
| 38 | Ardelyx Inc | 122.394 | 781.060 $ | |
| 39 | Pfizer Inc | 27.500 | 772.200 $ | |
| 40 | BOUNDLESS BIO INC | 678.574 | 746.431 $ | |
| 41 | Ascendis Pharma A/S | 2.800 | 728.276 $ | |
| 42 | ArriVent Biopharma Inc | 30.013 | 720.430 $ | |
| 43 | Structure Therapeutics Inc | 14.102 | 710.805 $ | |
| 44 | Bridgebio Pharma Inc | 8.100 | 687.276 $ | |
| 45 | ARS Pharmaceuticals Inc | 79.150 | 676.672 $ | |
| 46 | BEONE MEDICINES LTD | 1.870 | 631.061 $ | |
| 47 | Tectonic Therapeutic Inc | 19.059 | 628.215 $ | |
| 48 | Ionis Pharmaceuticals Inc | 7.200 | 617.240 $ | |
| 49 | BioMarin Pharmaceutical Inc | 9.450 | 607.268 $ | |
| 50 | Kura Oncology Inc | 71.480 | 606.010 $ | |
| 51 | Privia Health Group Inc | 27.136 | 558.188 $ | |
| 52 | Cytokinetics Inc | 7.300 | 544.614 $ | |
| 53 | PTC Therapeutics Inc | 6.650 | 515.063 $ | |
| 54 | AGOMAB THERAPEUTICS SA | 43.500 | 477.295 $ | |
| 55 | Alignment Healthcare Inc | 26.911 | 474.172 $ | |
| 56 | Hinge Health Inc | 12.244 | 472.129 $ | |
| 57 | RadNet Inc | 7.999 | 447.064 $ | |
| 58 | Biogen Inc | 1.850 | 385.910 $ | |
| 59 | Inspire Medical Systems Inc | 7.225 | 372.666 $ | |
| 60 | Neurocrine Biosciences Inc | 2.300 | 343.841 $ | |
| 61 | ORIC Pharmaceuticals Inc | 23.500 | 332.651 $ | |
| 62 | Omada Health Inc | 25.620 | 322.043 $ | |
| 63 | Abivax SA | 2.340 | 297.861 $ | |
| 64 | Illumina Inc | 2.132 | 296.071 $ | |
| 65 | Axsome Therapeutics Inc | 1.500 | 289.869 $ | |
| 66 | Incyte Corp | 2.350 | 254.124 $ | |
| 67 | Moderna Inc | 4.350 | 247.904 $ | |
| 68 | Medpace Holdings Inc | 430 | 228.090 $ | |
| 69 | Guardant Health Inc | 1.980 | 205.523 $ | |
| 70 | Revolution Medicines Inc | 1.830 | 202.280 $ | |
| 71 | Palisade Bio Inc | 88.000 | 172.375 $ | |